Desirée Hao

2.4k total citations · 1 hit paper
90 papers, 1.5k citations indexed

About

Desirée Hao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Desirée Hao has authored 90 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 36 papers in Pulmonary and Respiratory Medicine and 21 papers in Molecular Biology. Recurrent topics in Desirée Hao's work include Lung Cancer Treatments and Mutations (30 papers), Head and Neck Cancer Studies (13 papers) and Cancer Genomics and Diagnostics (10 papers). Desirée Hao is often cited by papers focused on Lung Cancer Treatments and Mutations (30 papers), Head and Neck Cancer Studies (13 papers) and Cancer Genomics and Diagnostics (10 papers). Desirée Hao collaborates with scholars based in Canada, United States and Germany. Desirée Hao's co-authors include Harold Lau, Alexander C. Klimowicz, Anthony M. Magliocco, Brian O’Sullivan, Stephanie Petrillo, D. Gwyn Bebb, Janessa Laskin, Alessandro Morabito, James Chih‐Hsin Yang and Balázs Halmos and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Desirée Hao

83 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis

2025 18 citations Wenpin Qin, Guo Dong Bai et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Desirée Hao Canada	23	842	633	469	282	201	90	1.5k
Jenny Huang United States	10	431 0.5×	350 0.6×	406 0.9×	255 0.9×	484 2.4×	19	1.4k
Wen‐Wei Sung Taiwan	20	630 0.7×	371 0.6×	580 1.2×	232 0.8×	265 1.3×	91	1.5k
Morena Fasano Italy	20	680 0.8×	535 0.8×	605 1.3×	139 0.5×	244 1.2×	63	1.4k
Dinesh Chandra Doval India	24	1.2k 1.4×	673 1.1×	323 0.7×	367 1.3×	428 2.1×	101	1.9k
Wen-Qiong Xue China	16	437 0.5×	211 0.3×	615 1.3×	244 0.9×	415 2.1×	17	1.3k
Shunzo Hatooka Japan	23	1.1k 1.3×	1.5k 2.3×	563 1.2×	415 1.5×	291 1.4×	45	2.2k
Enzo Maria Ruggeri Italy	22	681 0.8×	535 0.8×	274 0.6×	354 1.3×	279 1.4×	103	1.4k
Veronica Lonati Italy	22	1.3k 1.5×	656 1.0×	296 0.6×	384 1.4×	405 2.0×	42	1.8k
Koichi Minato Japan	29	2.1k 2.4×	1.6k 2.5×	781 1.7×	306 1.1×	364 1.8×	171	3.1k
Diane Savarese United States	16	576 0.7×	526 0.8×	274 0.6×	218 0.8×	184 0.9×	24	1.2k

Countries citing papers authored by Desirée Hao

Since Specialization

Citations

This map shows the geographic impact of Desirée Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Desirée Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Desirée Hao more than expected).

Fields of papers citing papers by Desirée Hao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Desirée Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Desirée Hao. The network helps show where Desirée Hao may publish in the future.

Co-authorship network of co-authors of Desirée Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Desirée Hao. A scholar is included among the top collaborators of Desirée Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Desirée Hao. Desirée Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jinjin, Hui Wang, Li Chen, et al.. (2025). Gut microbiota analysis reveals microbial signature for multi-autoimmune diseases based on machine learning model. Frontiers in Microbiology. 16. 1660775–1660775.

Qin, Wenpin, Guo Dong Bai, Wen Qin, et al.. (2025). Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis. Nature Communications. 16(1). 1390–1390. 18 indexed citations breakdown →

Sinnarajah, Aynharan, Sadia Ahmed, Desirée Hao, et al.. (2025). Patient-Rated Acceptability of Automatic Palliative Care Referral: A Prospective Cohort Study. Journal of Pain and Symptom Management. 69(5). 465–472.

Bennett, Bryan, Grant D. Stewart, Ana Medina, et al.. (2023). Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck. Cancers. 15(14). 3552–3552. 2 indexed citations

Ruan, Yibing, Emily Heer, Matthew T. Warkentin, et al.. (2023). The association between neighborhood‐level income and cancer stage at diagnosis and survival in Alberta. Cancer. 130(4). 563–575. 3 indexed citations

Ezeife, Doreen A., Eldon Spackman, Rosalyn A. Juergens, et al.. (2022). The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 14. 27 indexed citations

Ho, Alan L., Daniel W. Bowles, Caroline Even, et al.. (2021). 904P ACCURACY: A phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut): Results of 6-mg cohort. Annals of Oncology. 32. S803–S804. 6 indexed citations

Laurie, Scott A., Jason Agulnik, Desirée Hao, et al.. (2020). 1195P The value of detecting resistance through liquid biopsy. Annals of Oncology. 31. S786–S787. 1 indexed citations

Hochmair, Maximilian J., Alessandro Morabito, Desirée Hao, et al.. (2018). OA03 Afatinib Followed by Osimertinib in Real-World Patients with EGFR Mutation-Positive Advanced NSCLC: The Giotag Study. Journal of Thoracic Oncology. 13(12). S1045–S1045. 1 indexed citations

10.

Hochmair, Maximilian J., Alessandro Morabito, Desirée Hao, et al.. (2018). Afatinib followed by osimertinib in patients with EGFR mutation-positive advanced NSCLC: A real-world study (GioTag). Annals of Oncology. 29. ix176–ix177. 1 indexed citations

11.

Juergens, Rosalyn A., Desirée Hao, Scott A. Laurie, et al.. (2017). MA09.03 Cisplatin/Pemetrexed + Durvalumab +/- Tremelimumab in Pts with Advanced Non-Squamous NSCLC: A CCTG Phase IB Study - IND.226. Journal of Thoracic Oncology. 12(1). S392–S393. 11 indexed citations

12.

Ko, Jenny J., Jodi Siever, Desirée Hao, Richard J. Simpson, & Harold Lau. (2016). Adenoid Cystic Carcinoma of Head and Neck: Clinical Predictors of Outcome from a Canadian Centre. Current Oncology. 23(1). 26–33. 49 indexed citations

13.

Hao, Desirée, et al.. (2016). Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment. Metabolomics. 12(3). 58–58. 60 indexed citations

14.

Wakelee, Heather A., Chris H. Takimoto, Arturo Lopez‐Anaya, et al.. (2011). The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 69(2). 563–571. 17 indexed citations

15.

Klimowicz, Alexander C., Karen Kopciuk, Stephanie Petrillo, et al.. (2011). CXCR4 Overexpression Is Associated with Poor Outcome in Females Diagnosed with Stage IV Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(7). 1169–1178. 60 indexed citations

16.

Doll, Corinne, Misha Eliasziw, Alexander C. Klimowicz, et al.. (2010). Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone. Radiotherapy and Oncology. 97(2). 352–359. 27 indexed citations

17.

Lin, Chia‐Chi, Muralidhar Beeram, Eric K. Rowinsky, et al.. (2009). Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies. Cancer Chemotherapy and Pharmacology. 65(1). 167–175. 2 indexed citations

18.

Tolcher, Anthony W., Desirée Hao, Johann S. de Bono, et al.. (2006). Phase I, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered Ad5CMV-p53, an Adenoviral Vector Containing the Wild-Type p53 Gene, in Patients With Advanced Cancer. Journal of Clinical Oncology. 24(13). 2052–2058. 34 indexed citations

19.

Ricart, Alejandro D., Anthony W. Tolcher, Quincy S. Chu, et al.. (2006). Phase I study of BMS-247550, an epothilone B analog, administered weekly for 3 weeks followed by a one-week break in patients (pts) with advanced malignancies. Cancer Research. 66. 685–685. 3 indexed citations

20.

Hao, Desirée & Manuel Hidalgo. (2002). Promising Developments in Targeted Therapies for non–small-Cell Lung Cancer. Clinical Lung Cancer. 4(2). 111–123. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact